Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Structural equation modeling for identifying the drivers of health-related quality of life improvement experienced by patients with migraine receiving eptinezumab

    As new migraine therapies emerge, it is crucial for measures to capture the complexities of health-related quality of life (HRQoL) improvement beyond improvements in monthly migraine day (MMD) reduction. Inves...

    Linus Jönsson, Susanne F. Awad, Stephane A. Regnier in The Journal of Headache and Pain (2024)

  2. Article

    Open Access

    Progression analysis versus traditional methods to quantify slowing of disease progression in Alzheimer’s disease

    The clinical meaningfulness of the effects of recently approved disease-modifying treatments (DMT) in Alzheimer’s disease is under debate. Available evidence is limited to short-term effects on clinical rating...

    Linus Jönsson, Milana Ivkovic, Alireza Atri, Ron Handels in Alzheimer's Research & Therapy (2024)

  3. Article

    Open Access

    Health-related quality of life in subjective cognitive decline and mild cognitive impairment: a longitudinal cohort analysis

    Health-related quality of life (HR-QoL) is an important outcome for patients and crucial for demonstrating the value of new treatments. Health utility estimates in subjective cognitive decline (SCD) and mild c...

    Sandar Aye, Vincent Bouteloup, Ashley Tate, Anders Wimo in Alzheimer's Research & Therapy (2023)

  4. Article

    Open Access

    The association of feeding difficulties and generic health-related quality of life among children born with esophageal atresia

    Children born with esophageal atresia experience feeding difficulties. This study investigates the association of feeding difficulties and generic health-related quality of life among children aged 2–7 and 8–1...

    Sofie Örnö Ax, Michaela Dellenmark-Blom in Orphanet Journal of Rare Diseases (2023)

  5. Article

    Open Access

    Estimating the Product Lifecycle Value of Trastuzumab Based on Registry Data in Sweden

    Trastuzumab was introduced in Sweden in 2000 for treatment of HER2-positive metastatic breast cancer (MBC) and later expanded to early breast cancer (EBC). The potential value of this innovative therapy was ex...

    Nahila Justo, Nils Wilking, Linus Jönsson in Clinical Drug Investigation (2023)

  6. Article

    Open Access

    The Costs of Dementia in Europe: An Updated Review and Meta-analysis

    The prevalence of dementia is increasing, while new opportunities for diagnosing, treating and possibly preventing Alzheimer’s disease and other dementia disorders are placing focus on the need for accurate es...

    Linus Jönsson, Ashley Tate, Oskar Frisell, Anders Wimo in PharmacoEconomics (2023)

  7. Article

    Open Access

    A longitudinal study on quality of life along the spectrum of Alzheimer’s disease

    Quality of life (QoL) is an important outcome from the perspective of patients and their caregivers, in both dementia and pre-dementia stages. Yet, little is known about the long-term changes in QoL over time....

    Arenda Mank, Judith J. M. Rijnhart, Ingrid S. van Maurik in Alzheimer's Research & Therapy (2022)

  8. Article

    Open Access

    Postoperative morbidity and health-related quality of life in children with delayed reconstruction of esophageal atresia: a nationwide Swedish study

    In 10–15% of children with esophageal atresia (EA) delayed reconstruction of esophageal atresia (DREA) is necessary due to long-gap EA and/or prematurity/low birth weight. They represent a patient subgroup wit...

    Michaela Dellenmark-Blom, Sofie Örnö Ax, Elin Öst in Orphanet Journal of Rare Diseases (2022)

  9. Article

    Open Access

    Factors of family impact in a Swedish–German cohort of children born with esophageal atresia

    After repair of esophageal atresia (EA), childhood survivors commonly present with digestive and respiratory morbidity, and around 55% have associated anomalies. Although it is known that these problems can re...

    Michaela Dellenmark-Blom, Kate Abrahamsson in Orphanet Journal of Rare Diseases (2022)

  10. Article

    Open Access

    Predicting time to relapse in patients with schizophrenia according to patients’ relapse history: a historical cohort study using real-world data in Sweden

    For patients with schizophrenia, relapse is a recurring feature of disease progression, often resulting in substantial negative impacts for the individual. Although a patient’s relapse history (specifically th...

    Kristian Tore Jørgensen, Martin Bøg, Madhu Kabra, Jacob Simonsen in BMC Psychiatry (2021)

  11. Article

    Open Access

    Parent–child-agreement on health-related quality of life and its determinants in patients born with Esophageal Atresia: a Swedish–German cross-sectional study

    The aim was to compare parent and child-reported health-related quality of life (HRQOL) of children born with esophageal atresia (EA) and determine factors that affect the level of parent–child agreement.

    Stefanie Witt, Michaela Dellenmark-Blom in Orphanet Journal of Rare Diseases (2021)

  12. Article

    Open Access

    Transdiagnostic individualized clinically-based risk calculator for the automatic detection of individuals at-risk and the prediction of psychosis: external replication in 2,430,333 US patients

    The real-world impact of psychosis prevention is reliant on effective strategies for identifying individuals at risk. A transdiagnostic, individualized, clinically-based risk calculator to improve this has bee...

    Dominic Oliver, Chiew Meng Johnny Wong, Martin Bøg in Translational Psychiatry (2020)

  13. Article

    Open Access

    Inventory of real world data sources in Parkinson’s disease

    Real world data have an important role to play in the evaluation of epidemiology and burden of disease; and in assisting health-care decision-makers, especially related to coverage and payment decisions. Howev...

    Audrey Tanguy, Linus Jönsson, Lianna Ishihara in BMC Neurology (2017)

  14. Article

    Open Access

    Erratum to: The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care

    Anders Wimo, Linus Jönsson, Laura Fratiglioni in Alzheimer's Research & Therapy (2017)

  15. Article

    Open Access

    The societal costs of dementia in Sweden 2012 – relevance and methodological challenges in valuing informal care

    In this study, we sought to estimate the societal cost of illness in dementia in Sweden in 2012 using different costing approaches to highlight methodological issues.

    Anders Wimo, Linus Jönsson, Laura Fratiglioni in Alzheimer's Research & Therapy (2016)

  16. No Access

    Article

    Health-related quality of life among children, young people and adults with esophageal atresia: a review of the literature and recommendations for future research

    Esophageal atresia (EA) is a rare congenital malformation requisite of surgical treatment. Survival rates have significantly increased in recent decades, but treated children are at risk of chronic morbidity. ...

    Michaela Dellenmark-Blom, John Eric Chaplin, Vladimir Gatzinsky in Quality of Life Research (2015)

  17. No Access

    Article

    Disease progression and costs of care in Alzheimer’s disease patients treated with donepezil: a longitudinal naturalistic cohort

    Improved data and methods are needed for modeling disease progression in Alzheimer’s disease (AD) for economic evaluation of treatments. The aim is to estimate prediction models for long-term AD progression an...

    Anders Gustavsson, Linus Jönsson, Johan Parmler in The European Journal of Health Economics (2012)

  18. No Access

    Article

    Cost-effectiveness of exemestane versus tamoxifen as adjuvant therapy for early-stage breast cancer after 2–3 years treatment with tamoxifen in Sweden

    Aromatase inhibitors are rapidly becoming the cornerstone of endocrine treatment for advanced disease and are now also used as adjuvant treatment in early-stage disease. The objective of this study was to asse...

    Jonas Lundkvist, Nils Wilking, Stig Holmberg in Breast Cancer Research and Treatment (2007)

  19. No Access

    Article

    Lipid Management and Cholesterol Goal Attainment in Norway

    To document prescribing patterns of lipid-modifying therapies in hypercholesterolemic patients, cholesterol goal attainment, and factors associated with cholesterol goal attainment in Norway.

    Dr Leiv Ose, Finn E. Skjeldestad in American Journal of Cardiovascular Drugs (2006)

  20. No Access

    Article

    The economic and quality of life impact of hypoglycemia

    Hypoglycemia is an often underrecognized side effect of type 2 diabetes therapy. This study assessed the burden of hypoglycemia in this population in Sweden and included 309 patients aged 35 years or older and...

    Jonas Lundkvist, Christian Berne in The European Journal of Health Economics (2005)

previous disabled Page of 2